Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation
- PMID: 22030098
- PMCID: PMC3253922
- DOI: 10.1016/j.ymgme.2011.09.030
Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation
Abstract
Background: The use of long-chain fatty acids (LCFAs) for energy is inhibited in inherited disorders of long-chain fatty acid oxidation (FAO). Increased energy demands during exercise can lead to cardiomyopathy and rhabdomyolysis. Medium-chain triglycerides (MCTs) bypass the block in long-chain FAO and may provide an alternative energy substrate to exercising muscle.
Objectives: To determine the influence of isocaloric MCT versus carbohydrate (CHO) supplementation prior to exercise on substrate oxidation and cardiac workload in participants with carnitine palmitoyltransferase 2 (CPT2), very long-chain acyl-CoA dehydrogenase (VLCAD) and long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD) deficiencies.
Design: Eleven subjects completed two 45-minute, moderate intensity, treadmill exercise studies in a randomized crossover design. An isocaloric oral dose of CHO or MCT-oil was administered prior to exercise; hemodynamic and metabolic indices were assessed during exertion.
Results: When exercise was pretreated with MCT, respiratory exchange ratio (RER), steady state heart rate and generation of glycolytic intermediates significantly decreased while circulating ketone bodies significantly increased.
Conclusions: MCT supplementation prior to exercise increases the oxidation of medium chain fats, decreases the oxidation of glucose and acutely lowers cardiac workload during exercise for the same amount of work performed when compared with CHO pre-supplementation. We propose that MCT may expand the usable energy supply, particularly in the form of ketone bodies, and improve the oxidative capacity of the heart in this population.
Trial registration: ClinicalTrials.gov NCT00654004.
Copyright © 2011 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest:
The authors have no conflicts of interest relevant to this article to disclose.
Figures





References
-
- den Boer ME, Wanders RJ, Morris AA, L IJ, Heymans HS, Wijburg FA. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics. 2002;109(1):99–104. - PubMed
-
- Schaefer J, Jackson S, Dick DJ, Turnbull DM. Trifunctional enzyme deficiency: adult presentation of a usually fatal beta-oxidation defect. Ann Neurol. 1996 Oct;40(4):597–602. - PubMed
-
- Vici CD, Burlina AB, Bertini E, et al. Progressive neuropathy and recurrent myoglobinuria in a child with long- chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. J Pediatr. 1991;118(5):744–746. - PubMed
-
- Gillingham MB, Scott B, Elliott D, Harding CO. Metabolic control during exercise with and without medium-chain triglycerides (MCT) in children with long-chain 3-hydroxy acyl-CoA dehydrogenase (LCHAD) or trifunctional protein (TFP) deficiency. Mol Genet Metab. 2006 Sep–Oct;89(1–2):58–63. - PMC - PubMed
-
- Bonnet D, Martin D, Pascale De L, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation. 1999 Nov 30;100(22):2248–2253. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous